• About Us
  • Board of Advisors
  • Contact

MALARIA.com

A Malaria Information and Community Portal

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
Home / Archives for Bill & Melinda Gates Foundation

WHO Launches Program to Counter Drug-Resistant Malaria

May 16, 2013 By Malaria.com Leave a Comment

On World Malaria Day, the World Health Organization has launched an emergency program in Phnom Penh to tackle a worrying regional trend - a strain of malaria that is proving resistant to the most important anti-malarial drug. Six years ago, health researchers were worried after a strain of malaria in western Cambodia began to show resistance to the world’s key malaria treatment - … [Read more...]

Filed Under: Malaria News Tagged With: ACTs, artemisinin resistance, Bill & Melinda Gates Foundation, Cambodia, Stephen Bjorge, World Health Organization (WHO)

Phase III Trial of RTS,S Malaria Candidate Vaccine Reduces Malaria by One Third

November 9, 2012 By Malaria.com Leave a Comment

Results from a pivotal, large-scale Phase III trial, published online today in the New England Journal of Medicine, show that the RTS,S malaria vaccine candidate can help protect African infants against malaria. When compared to immunization with a control vaccine, infants (aged 6-12 weeks at first vaccination) vaccinated with RTS,S had one-third fewer episodes of both clinical and severe malaria … [Read more...]

Filed Under: Malaria News Tagged With: Andrew Witty, Bill & Melinda Gates Foundation, Bill Gates, David Kaslow, GlaxoSmithKline, Malaria Vaccine, PATH Malaria Vaccine Initiative (MVI), RTSS Vaccine, Salim Abdulla

Gates Foundation Offers USD$100K Grants for Innovative Global Health and Development Projects

September 5, 2012 By Malaria.com Leave a Comment

The Bill & Melinda Gates Foundation announced today that it is accepting applications for Round 10 of its Grand Challenges Explorations initiative, a USD$100 million grant initiative encouraging innovation in global health and development research.  Anyone with a transformative idea is invited to submit an easy, online, two page application. Grand Challenges Explorations is pleased to have … [Read more...]

Filed Under: Malaria News Tagged With: Bill & Melinda Gates Foundation, Gates Foundation, Grand Challenges, Grand Challenges Exploration Grant

Malaria Nearly Eliminated in Sri Lanka Despite Decades of Conflict

August 29, 2012 By Malaria.com Leave a Comment

UCSF, Sri Lankan Researchers Credit Adaptability of Malaria Control Program Despite nearly three decades of conflict, Sri Lanka has succeeded in reducing malaria cases by 99.9% since 1999 and is on track to eliminate the disease entirely by 2014. According to a paper published today in the online, open-access journal PLOS ONE, researchers from Sri Lanka’s Anti-Malaria Campaign and the UCSF … [Read more...]

Filed Under: Malaria News Tagged With: Bill & Melinda Gates Foundation, Gawrie Galappaththy, PLoS One, Sri Lanka, UCSF, UCSF Global Health Group

Genetically Engineered Bacteria Prevent Mosquitoes From Transmitting Malaria

July 16, 2012 By Malaria.com Leave a Comment

Researchers at the Johns Hopkins Malaria Research Institute have genetically modified a bacterium commonly found in the mosquito’s midgut and found that the parasite that causes malaria in people does not survive in mosquitoes carrying the modified bacterium. The bacterium, Pantoea agglomerans, was modified to secrete proteins toxic to the malaria parasite, but the toxins do not harm the mosquito … [Read more...]

Filed Under: Malaria News Tagged With: Anil K. Ghosh, Bill & Melinda Gates Foundation, Bloomberg Family Foundation, David J. Lampe, Gates Foundation, Johns Hopkins Malaria Research Institute, Kevin A. Stebbings, Marcelo Jacobs-Lorena, Nicholas Bongio, P. agglomerans, Pantoea agglomerans, Plasmodium berghei, Plasmodium Falciparum, Sibao Wang

Contrasting Patterns of Malaria Drug Resistance Found Between Humans and Mosquitoes

November 15, 2011 By Malaria.com Leave a Comment

A recent study has detected contrasting patterns of drug resistance in malaria-causing parasites taken from both humans and mosquitoes in rural Zambia. Parasites found in human blood samples showed a high prevalence for pyrimethamine-resistance, which was consistent with the class of drugs widely used to treat malaria in the region. However, parasites taken from mosquitoes themselves had very … [Read more...]

Filed Under: Malaria News Tagged With: Bill & Melinda Gates Foundation, Clive J. Shiff, David J. Sullivan, Johns Hopkins Malaria Research Institute, Kun Liu, Mtawa A. P. Mkulama, Mulenga Musapa, Peter Agre, Philip E. Thuma, Plasmodium Falciparum, Pyrimethamine Resistance, Sandra Chishimba, Sungano Mharakurwa, Taida Kumwenda, Zambia

Glaxo’s RTS,S Malaria Vaccine Shows Promise

October 19, 2011 By Malaria.com Leave a Comment

Preliminary results from the trial of a malaria vaccine show that it protected nearly half of the children who received it from bouts of serious malaria, scientists said Tuesday. The vaccine, known as RTS,S and made by GlaxoSmithKline, has been in development for more than 25 years, initially for the American military and now with most of its support from the Bill and Melinda Gates Foundation. … [Read more...]

Filed Under: Malaria News Tagged With: Bill & Melinda Gates Foundation, Gates Foundation, GlaxoSmithKline, Malaria Vaccine, RTSS Vaccine

Study Finds Malaria Vaccine Candidate, RTS,S Significantly Reduces Malaria Risk in African Infants

October 18, 2011 By Malaria.com Leave a Comment

First results from a large-scale Phase III trial of RTS,S*, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & … [Read more...]

Filed Under: Malaria News Tagged With: Agenus Inc., Antigenics Inc., Bill & Melinda Gates Foundation, Francis Martinson, GlaxoSmithKline, Irving Hoffman, Malawi, PATH Malaria Vaccine Initiative (MVI), QS-21 Stimulon, RTSS Vaccine

RTS,S Malaria Vaccine

October 8, 2011 By Malaria Q&A 10 Comments

QUESTION: What information can you provide on this vaccine candidate? ANSWER: RTS,S is a vaccine candidate against Plasmodium falciparum malaria which works by encouraging the host's body to produce antibodies and T cells which diminish the malaria parasite's ability to survive and reproduce in the liver. Produced by GlaxoSmithKline, RTS,S is the first vaccine candidate against … [Read more...]

Filed Under: Malaria Q&A Tagged With: antibody productive, Bill & Melinda Gates Foundation, Gates Foundation, GlaxoSmithKline, Malaria Vaccine, Malaria Vaccine Initiative, PATH Malaria Vaccine Initiative (MVI), Phase III clinical trials, Plasmodium Falciparum, RTSS Vaccine

Microwaves Against Malaria

August 12, 2011 By Malaria.com Leave a Comment

The Bill & Melinda Gates Foundation today announced that twelve grantees have advanced to the next level of Grand Challenges Explorations (GCE), an initiative that enables researchers worldwide to test unorthodox ideas that address persistent health and development challenges. The grantees will receive additional funding to continue Phase II of their research over a two-year … [Read more...]

Filed Under: Malaria News Tagged With: Bill & Melinda Gates Foundation, Carmenza Spadafora, Chris Wilson, Grand Challenges Exploration Grant, Jose Stoute, Microwaves

Next Page »

Stay Informed

WWARN Corner

About WWARN

The WorldWide Antimalarial Resistance Network (WWARN) generates innovative resources and reliable evidence to inform the malaria community on the factors affecting the efficacy of antimalarial medicines. Learn more…

  • Fighting Malaria Requires Protecting the Effectiveness of Antimalarial Medicines
  • Data Sharing at IDDO
  • Evidence to inform equitable dosing in very young and malnourished children

More WWARN Stories...

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
  • About Us
  • Board of Advisors
  • Contact

Copyright © 2023 Malaria.com · Log in